L-Theanine for Anxiety

Verdict: May ease everyday stress, unproven for clinical anxiety

L-theanine shows modest, short-term promise for calming everyday stress and subclinical tension in healthy adults, but the evidence is weak and it has not been shown to treat diagnosed anxiety disorders. It is not a substitute for standard anxiety care.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

This earns a Weak (Tier C) grade because the supportive evidence sits almost entirely in healthy or moderately stressed people, not in people with diagnosed anxiety. Small short-term RCTs found that 200-400 mg/day, or even a single 200 mg dose, lowered perceived stress, state/trait anxiety scores, and salivary cortisol (PMID 38758503, PMID 34562208, PMID 31623400), and two systematic reviews leaned positive for stress and anxiety symptoms (PMID 39633316, PMID 31758301).

The crucial caveat is the gap between feeling stressed and a clinical diagnosis. The single trial in DSM-5 generalized anxiety disorder added L-theanine to antidepressants and did not beat placebo on the main HAM-A anxiety measure (PMID 30580081, p=0.73). Trials are also small (largest n=46), doses range widely with no clear dose-response, no review pooled a quantitative effect, and several positive trials were industry-funded, which is why the engine flags weak, mixed evidence.

Authorities reinforce caution rather than endorsement. The US FDA treats L-theanine as generally recognized as safe but backs safety only, not any anxiety claim, while the EU's EFSA concluded a cause-and-effect relationship has not been established for its proposed mental-health benefits. The Cleveland Clinic says it may promote relaxation without drowsiness yet should not replace standard treatment, and major bodies like the NIH, Mayo Clinic, and Harvard offer no dedicated endorsement.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.46
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
81%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.53
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.455
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (6)L2 · primary research & systematic reviews

The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review
PMID: 39633316 2024 系統性回顧 n = 11
Finding: L-theanine supplementation reduced psychiatric symptoms more effectively than control conditions in individuals with schizophrenia, anxiety disorders, and ADHD; authors caution about scarcity of studies and lack of standardized dosing
View on PubMed
Safety and Efficacy of AlphaWave L-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial
PMID: 38758503 2024 RCT (double-blind) n = 30
Finding: L-theanine group showed reductions in PSS of 12.92% at day 14 and 17.98% at day 28 vs placebo; supportive but small sample (n=30) limits external validity
🟠 Limited quality ⚠️ Industry-funded Effect size: [object Object]
View on PubMed
A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave L-Theanine on Stress in a Healthy Adult Population
PMID: 34562208 2021 RCT (double-blind) n = 16
Finding: Single 200 mg dose significantly increased frontal alpha power at 3 h (p=0.038) and reduced salivary cortisol at 1 h (p<0.001) vs placebo; consistent with acute anxiolytic/relaxation effect, but very small n=16 and acute design limit generalizability
🟠 Limited quality ⚠️ Industry-funded
View on PubMed
The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
PMID: 31758301 2020 系統性回顧 n = 9
Finding: 200-400 mg/day L-theanine may assist reduction of stress and anxiety under stressful conditions; authors note longer/larger trials still needed before therapeutic claims
View on PubMed
L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial
PMID: 30580081 2019 RCT (double-blind) n = 46
Finding: Adjunctive L-theanine did NOT outperform placebo on HAM-A in DSM-5 GAD (p=0.73); secondary benefit observed for sleep satisfaction (ISI item 4, p=0.015) and insomnia subgroup
Mixed funding
View on PubMed
Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial
PMID: 31623400 2019 RCT (double-blind) n = 30
Finding: 200 mg/day for 4 weeks reduced stress-related symptom scores (SDS, STAI-trait) and improved sleep (PSQI) vs placebo in healthy adults; small n=30 and crossover design
⚠️ Industry-funded
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
FDA has no questions source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of L-theanine from Camellia sinensis and improvement of cognitive function source↗
L4d TW TFDA / 衛福部
Neutral
茶氨酸為茶葉中天然存在之胺基酸成分 source↗
L5c Cleveland Clinic
Cautious
L-theanine may help promote relaxation without drowsiness source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬6 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-anxiety-INT-l-theanine-001 繁體中文版 →